Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
November 15, 1991
Mechanism-based inactivation of alanine racemase by 3-halovinylglycines
N A Thornberry, H G Bull, D Taub, et al.
Biochemical and Biophysical Research Communications
|
November 30, 1983
Benzolactams. A new class of converting enzyme inhibitors
W H Parsons, J L Davidson, D Taub, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 1999
Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues
M H Chen, P P Pollard, A A Patchett, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Tripeptide growth hormone secretagogues
L Yang, G Morriello, Y Pan, et al.
Journal of Medicinal Chemistry
|
September 1, 1991
Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors
A E Weber, T A Halgren, J J Doyle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1992
In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist
R S Chang, P K Siegl, B V Clineschmidt, et al.
Biochemistry
|
June 27, 1989
Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells
R Saperstein, P P Vicario, H V Strout, et al.
Journal of Medicinal Chemistry
|
September 1, 1988
Phosphinic acid inhibitors of D-alanyl-D-alanine ligase
W H Parsons, A A Patchett, H G Bull, et al.
Experientia
|
January 15, 1991
1-(substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors of Trypanosoma cruzi in mice
J C Chabala, V B Waits, T Ikeler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 18, 1995
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue
A A Patchett, R P Nargund, J R Tata, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
November 15, 1991
Mechanism-based inactivation of alanine racemase by 3-halovinylglycines
N A Thornberry, H G Bull, D Taub, et al.
Biochemical and Biophysical Research Communications
|
November 30, 1983
Benzolactams. A new class of converting enzyme inhibitors
W H Parsons, J L Davidson, D Taub, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 1999
Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues
M H Chen, P P Pollard, A A Patchett, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Tripeptide growth hormone secretagogues
L Yang, G Morriello, Y Pan, et al.
Journal of Medicinal Chemistry
|
September 1, 1991
Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors
A E Weber, T A Halgren, J J Doyle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1992
In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist
R S Chang, P K Siegl, B V Clineschmidt, et al.
Biochemistry
|
June 27, 1989
Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells
R Saperstein, P P Vicario, H V Strout, et al.
Journal of Medicinal Chemistry
|
September 1, 1988
Phosphinic acid inhibitors of D-alanyl-D-alanine ligase
W H Parsons, A A Patchett, H G Bull, et al.
Experientia
|
January 15, 1991
1-(substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors of Trypanosoma cruzi in mice
J C Chabala, V B Waits, T Ikeler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 18, 1995
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue
A A Patchett, R P Nargund, J R Tata, et al.
Page
of 7